First Year of Lenacapavir Long-Acting Injectable Use in the OPERA Cohort

Conference Reports for NATAP

Conference on Retroviruses
and Opportunistic Infections
San Francisco, CA
March 9-12 2025


First Year of Lenacapavir Long-Acting Injectable Use in the OPERA Cohort

	CROI 2025 SF March 9-12 Gregory Fusco,Jennifer S Fusco,Joshua S Gruber,Karam C Mounzer,Laurence Brunet,Michael G Sension,Ricky K Hsu